2 Recent Developments in Aromatase Inhibition as a Potential Treatment for Oestrogen-Dependent Breast Cancer
- 1 January 1989
- book chapter
- Published by Elsevier
- Vol. 26, 253-298
- https://doi.org/10.1016/s0079-6468(08)70242-x
Abstract
No abstract availableThis publication has 149 references indexed in Scilit:
- Induction of tumour aromatase following treatment with aminoglutethimide-hydrocortisone in patients with breast cancerJournal of Steroid Biochemistry, 1987
- Inhibition of central nervous system aromatase activity: A mechanism for fenarimol-induced infertility in the male ratToxicology and Applied Pharmacology, 1987
- Analogs of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituentsJournal of Medicinal Chemistry, 1987
- Effect of 3-(4-aminophenyl)-3-ethylpyrrolidine-2,5-dione (WSP-1) on corticosterone production in the ratJournal of Steroid Biochemistry, 1987
- Inactivation of human placental aromatase by 6α- and 6β-hydroperoxyandrostenedioneBiochemical and Biophysical Research Communications, 1985
- Low-dose aminoglutethimide without steroid replacement in the treatment of postmenopausal women with advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1985
- The time-dependent inactivation of aromatase by 17β-hydroxy-10-methylthioestra-1,4-dien-3-oneBiochemical and Biophysical Research Communications, 1981
- Estrogen biosynthesis and 10-hydroxylation using C19 and 19-nor steroid precursorsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1976
- The effect of steroid hydroxylase inhibitors on the rate of reduction of adrenal mitochondrial cytochrome P-450Biochemical and Biophysical Research Communications, 1969
- Goitrous hypothyroidism inducedby an anticonvulsant drugThe Journal of Pediatrics, 1964